Highlights Alliance Pharma plc

Equities

Market Closed - London S.E. Other stock markets 11:35:03 2024-05-31 EDT			5-day change	1st Jan Change
38.8 ^GBX	-0.77%		-3.00%	-4.20%

05-30	Amberen, Brand of Alliance Pharma plc, Announces Launch of Amberen ENERGY MOOD SLEEP Gummies	CI
05-21	Alliance Pharma plc Announces the Appointment of Nicholas John Sedgwick as Director	CI

Amberen, Brand of Alliance Pharma plc, Announces Launch of Amberen ENERGY MOOD SLEEP Gummies	05-30	CI
Alliance Pharma drops as CEO departs, delays results again	05-09	AN
European Equities Close Higher in Wednesday Trading; Siemens Energy, Alliance Pharma CEOs to Step Down	05-08	MT
AIM WINNERS & LOSERS: Mobile Tornado wins deal; boohoo loss widens	05-08	AN
EARNINGS: Lok'n Store has "positive but muted" growth as Shurgard bids	04-22	AN
Alliance Pharma appoints chair; FireAngel sales down	02-05	AN
Alliance Pharma reports annual boost in revenue; eyes flat 2024 profit	01-29	AN
Alliance Pharma first half profit plunges, stops dividend payout	23-09-26	AN
Earnings Flash (APH.L) ALLIANCE PHARMA Posts H1 Revenue GBP81.4M	23-09-26	MT
Earnings Flash (APH.L) ALLIANCE PHARMA Posts H1 EPS GBX0.94	23-09-26	MT
Alliance Pharma plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-26	CI
Alliance Pharma plc Provides Earnings Guidance for the Second Half of 2023	23-09-26	CI
Alliance Pharma interim see-through revenue climbs	23-07-18	AN
Final dividend	23-06-21	FA
Alliance Pharma annual profit "marginally below" forecasts	23-05-25	AN
Alliance Pharma Four-Month Sales Rose on Year, But Sees Full-Year FX Hit	23-05-25	DJ
Alliance Pharma profit drops; Logistics Developments buys more shares	23-03-21	AN
Logistics Development buys Alliance Pharma shares for GBP6.8 million	23-03-21	AN
UK's Logistics Development Boosts Stake in Alliance Pharma	23-03-21	MT
Earnings Flash (APH.L) ALLIANCE PHARMA Posts FY22 Revenue GBP167.4M	23-03-21	MT

No results for this search